神经酶-2 是CB1受体的负调节剂
Yumna Abu Ghanem1, Liora Dorfman-Yahad1, Hadas Catane Hovav1
1Laboratory of Cellular and Molecular Psychiatry, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Biochemical pharmacology
|October 5, 2025
概括
神经因素-2,一种由压力诱导的蛋白质,减少了大麻素受体1 (CB1R) 的表达,影响了抑郁的途径. 这一发现为治疗抗常规疗法的严重抑郁症 (MDD) 提供了潜在的目标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 精神病学是一个精神病学.
背景情况:
- 大型抑郁症 (MDD) 影响全球数百万人,许多患者对当前的治疗反应不佳.
- 慢性压力是MDD的重要风险因素,导致神经生物学变化,但潜在的分子机制尚不清楚.
- 大麻素受体1 (CB1R) 与抑郁症有关,但其通过压力调节需要进一步研究.
研究的目的:
- 为了研究Neurensin-2的作用,一个压力诱导蛋白质,在调节CB1R信号传递.
- 在抑郁症的背景下阐明链接压力,神经酶-2和CB1R的分子机制.
主要方法:
- 使用N2a细胞进行体外研究,以检查Neurensin-2对CB1R表达和下游信号通路的影响 (Akt,mTOR,Erk1/2).
- 在体内研究使用慢性社会失败压力 (CSDS) 鼠标模型.
- 在压力条件下的野生类型和神经酶-2淘汰赛小鼠海马中神经酶-2 (Nrsn2) 和CB1R (Cnr1) 表达的分析.
- 免疫组合化学分析以确认在特定的神经元群体 (CCK阳性内部神经元) 中的同定位.
主要成果:
- 在N2a细胞中过度表达神经酶-2降低了CB1R表达,并减弱了Akt,mTOR和Erk1/2信号传递.
- 神经酶-2与CB1R共同局部化,降低了它在两个细胞区中的表达.
- 在小鼠海马体中,CSDS增加了Nrsn2并降低了Cnr1的表达.
- 压力诱导的Cnr1下调在Neurensin-2淘汰小鼠中被取消.
- 发现神经酶-2和CB1R在CCK阳性海马内部神经元中共同表达.
结论:
- 神经酶-2在海马体中压力诱导的CB1R下调中发挥着关键作用.
- 一个涉及神经酶-2的新途径在压力下抑制CB1R信号传递.
- 神经酶-2 是治疗耐药性抑郁症的潜在治疗标.
相关概念视频
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
822
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
822
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
583
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
583
Regulation of Food Intake
2.3K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K


